The combination of healthcare and AI is becoming increasingly close. The well-known consulting institution Fortune Business ...

CLEAN trial of endovascular therapy within 6 h of onset of ischaemic stroke caused by intracranial internal carotid or proximal middle cerebral artery occlusion were presented at the 9th World Stroke ...

Frankie Maldonado, Director of Operations with Life Guard Imaging joins Gayle Guyardo, the host of the global health and wellness show, Bloom, to discuss the best gift – the ...

A 32-year-old man was rearrested on Wednesday for a 2023 botched robbery that resulted in a shooting after charges were temporarily dropped. The Florida Cancer Specialists & Research Institute is ...

InspireMD Inc. NSPR recently announced the first patient enrolment in the company’s CGUARDIANS II clinical trial. The trial ...

Lake Street analyst Frank Takkinen initiated coverage of InspireMD (NSPR) with a Buy rating and $5 price target InspireMD’s CGuard carotid ...

The following is a summary of “Management of large or giant Extracranial carotid artery aneurysms: a single-center experience ...

InspireMD, Inc. announced that the first patient has been enrolled in the company’s CGUARDIANS II clinical trial evaluati ...

InspireMD enrolled the first patient in its CGUARDIANS II pivotal study, which will evaluate the CGuard Prime Carotid Stent ...

InspireMD (NSPR) announced that the first patient has been enrolled in the company’s CGUARDIANS II clinical trial evaluating its CGuard Prime ...

AdventHealth Gordon is hosting the AngioScreen bus from 8 a.m. to 3 p.m., Tuesday, Dec. 10. The AngioScreen bus will be parked in front of Resource Building 3 on the campus of AdventHealth Gordon. An ...

StockNews.com initiated coverage on shares of InspireMD (NYSE:NSPR – Free Report) in a research note released on Wednesday. The firm issued a sell rating on the stock. Separately, Piper Sandler ...